Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$17,966,069
in 2 filings, $18.0M under 10b5-1 plans

Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise 10b5-1 +786 $63.55 $50K 13,722
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Sale 10b5-1 −786 $163.49 $129K 12,936
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise 10b5-1 +1,600 $63.55 $102K 14,536
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Sale 10b5-1 −1,600 $164.84 $264K 12,936
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise 10b5-1 +200 $63.55 $13K 13,136
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Sale 10b5-1 −200 $166.04 $33K 12,936
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise 10b5-1 +300 $63.55 $19K 13,236
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Sale 10b5-1 −300 $167.85 $50K 12,936
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise 10b5-1 +1,133 $63.55 $72K 14,069
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Sale 10b5-1 −1,133 $169.10 $192K 12,936
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise 10b5-1 +210 $63.55 $13K 13,146
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Sale 10b5-1 −210 $169.75 $36K 12,936
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise 10b5-1 +134 $63.55 $9K 13,070
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Sale 10b5-1 −134 $171.66 $23K 12,936
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −2,500 35,000
2024-02-28 ROMANO KATHRYN Chief Accounting Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 30,000
2024-02-28 Krishnan Suma President, R&D Option exercise +7,500 1,579,353
2024-02-28 Krishnan Suma President, R&D Shares withheld for taxes −3,471 $163.08 $566K 1,575,882
2024-02-28 Krishnan Suma President, R&D Option exercise +12,500 1,643,047
2024-02-28 Krishnan Suma President, R&D Shares withheld for taxes −5,785 $163.08 $943K 1,637,262

Page 25 of 42 · 828 trades